CTOs on the Move

Alter G Inc

www.alter-g.com

 
Alter G Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Fremont, CA. To find more information about Alter G Inc, please visit www.alter-g.com
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.alter-g.com
  • 48438 Milmont Dr
    Fremont, CA USA 94538-7326
  • Phone: 510.270.5900

Executives

Name Title Contact Details

Similar Companies

Xenon Pharmateuticals

Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.

Women`s Health USA

Women`s Health USA is a provider of value-based care and practice management services to more than 600 women`s health providers across the U.S. With a unique focus on women, Women`s Health USA is an influential player in the development of new cost effective, value-based modes of care delivery. For 22 years, the company has successfully implemented innovative growth strategies and driven streamlined operational costs, payer alignment, ancillary services development, brand development strategies and risk management services. Its unique partnership model enables women`s health groups to operate independently, while leveraging the resources and influence of a national organization.

Prairie Health Ventures

Prairie Health Ventures is a Lincoln, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hims and Hers

Hims & Hers is a consumer-first platform transforming the way customers fulfill their health and wellness needs. Its digital platform enables access to treatments for a broad range of conditions, including those related to sexual health, hair loss, dermatology, mental health and primary care. Hims & Hers connects patients to licensed healthcare professionals who can prescribe medications when appropriate. Prescriptions are fulfilled online through licensed pharmacies on a subscription basis, making accessing treatments simple, affordable, and straightforward. Through the Hims & Hers mobile apps, consumers can access a range of educational programs, wellness content, community support, and other services that promote lifelong health and wellness. Hims & Hers products can also be found in tens of thousands of top retail locations in the United States. Launched in November 2017, Hims & Hers serves the entire United States and select locations in the United Kingdom. The company is publicly traded on the New York Stock Exchange.

MDC Group

MDC Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.